GSK diabetes drug Eperzan approved in Europe
The European Commission has granted marketing authorisation for GlaxoSmithKline's (GSK) once-weekly diabetes treatment, Eperzan (albiglutide).
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
27 Mar 14
The European Commission has granted marketing authorisation for GlaxoSmithKline's (GSK) once-weekly diabetes treatment, Eperzan (albiglutide).
24 Mar 14
Körber AG has completed the acquisition of Werum IT Solutions AG, based in Lüneburg, Germany, after the deal…
19 Mar 14
Cargill has officially inaugurated its newly expanded European Research and Development Centre in Vilvoorde, Belgium.
19 Mar 14
Ipsen has announced positive results from its phase IIa clinical trial assessing Dysport® in the treatment of neurogenic…
19 Mar 14
Researchers at the US Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) have discovered surprising new rules…
05 Mar 14
UDG Healthcare plc, a leading international provider of healthcare services, has agreed to acquire the healthcare communications business…
27 Feb 14
International technology group Körber is planning to acquire Werum IT Solutions AG − formerly Werum Software & Systems…
24 Feb 14
Arla Foods, a leading supplier of fresh dairy products to major retailers and foodservice customers, has announced its…
24 Feb 14
Pfizer Inc has announced that the 'Community-Acquired Pneumonia Immunisation Trial in Adults' (CAPiTA) − the landmark study of…
24 Feb 14
Scanning the patient's retina in seconds, a new ophthalmic-screening instrument could assist physicians in the diagnosis of glaucoma,…